You are here: Industry Insights > Market News > Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech

firstwordpharmaJuly 13, 2021

Tag: Covaxin , COVID-19 vaccine , WHO

Favorites

Bharat Biotech on Monday said it has submitted all documents required for the emergency use listing of its COVID-19 vaccine Covaxin to the World Health Organization (WHO), as reported by The Economic Times.

Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech

Last week, WHO chief scientist Soumya Swaminathan said the agency is likely to take a decision on Covaxin’s emergency use listing within four to six weeks.

"All documents required for Emergency Use Listing (EUL) of Covaxin have been submitted to WHO as of 9th July. The review process has now commenced with the expectation that we will receive EUL from WHO at the earliest," tweeted Bharat chairman Krishna Ella.

Previous:Pregnant women to receive Moderna COVID-19 vaccine in clinical trial

Next:Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors

Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>